Understanding Biologics and How They Differ

01 Mar 2010

Monday 1 March 2010

An ARCS Australia course aimed at Associates and Managers from pharma and biologics companies considering the development, marketing and reimbursement of biologics.

Speakers:

  • Susan Alexander, Director, Technical & Regulatory Affairs, Australia-New Zealand, Roche Products Pty Ltd
  • Mark Rowland, Director Regulatory Affairs, Amgen Australia Pty Ltd
  • Cammy Yuen, Director Market Access, Abbott Australia
  • Duncan Purvis, Senior Regulatory Affairs Project Manager, Janssen-Cilag Pty Ltd
  • Elizabeth de Somer, Regulatory Affairs Manager, Medicines Australia

Venue: Bio21 Institute Auditorium, 30 Flemington Road, Parkville

Time: 1.30 to 5.15pm

Course Fees:

ARCS Member - $112 incl.GST

Retired/Student Member - $84 incl.GST

Non Member - $140 incl.GST

How to register for events

Enquiries: Belinda King (02) 8905 0829, F: (02) 8905 0830, E: belindaking@arcs.com.au or
W: www.arcs.com.au